Glaxosmithkline
Sanofi, GSK to supply Covax with 200 million doses of coronavirus vaccine
Equity fund raising rises 88% to $32.7 bn in first 9 months of 2020
GlaxoSmithKline CEO optimistic Covid-19 vaccine widely available in 2021
Covid-19 vaccine makers must deliver to US in time to get full payments
US inks $1.5 bn deal with Moderna for 100 mn doses of Covid-19 'vaccine'

US FDA approves GlaxoSmithKline's experimental drug for blood cancer
US to pay Sanofi, GSK $2.1 bn for Covid-19 vaccine to cover 50 mn people
US books 100 mn Covid-19 vaccine doses for $2.1 bn from GSK, Sanofi Pasteur
Sanofi lifts earnings view as Regeneron stake sale boosts second quarter
GlaxoSmithKline Pharma Q1 net profit declines 2.38 pc to Rs 111 cr

GSK buys 10% stake of German biotech firm CureVac in $164-million deal
World Coronavirus Dispatch: WHO stops trials of HCQ, HIV cocktail
Covid-19 crisis: HUL hints at margin pressures, higher operating costs
Second-generation Covid-19 vaccines are built for impact over speed
J&J to begin human trials of Covid-19 vaccine in second half of July
GlaxoSmithKline Q4 consolidated net profit declines 6% to Rs 138 cr
Coronavirus vaccine not coming for at least 2 years: Novartis global CEO
GSK sells its entire 5.7% holding in HUL for over Rs 25,000 crore
GSK to offload HUL stake worth Rs 26,000 cr in largest secondary sale
GlaxoSmithKline plans sale of $3.7-billion stake in Hindustan Unilever